<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A woman with relapsing-remitting multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> (MS) was treated with oral <z:chebi fb="2" ids="2948">azathioprine</z:chebi> (AZA) for 4 years and subsequently switched to interferon-beta1a </plain></SENT>
<SENT sid="1" pm="."><plain>Five years later, <z:hpo ids='HP_0001882'>leukopenia</z:hpo> developed and resolved after interferon was discontinued; MS treatment was changed to <z:chebi fb="5" ids="53310">copolymer</z:chebi>-1 </plain></SENT>
<SENT sid="2" pm="."><plain>Recurrent <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> subsequently led to diagnosis of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) with deletion of the long arm of chromosome 5 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> 5q-) </plain></SENT>
<SENT sid="3" pm="."><plain>Within several months, unusually rapid for this subtype, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> progressed to secondary <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>While AZA is the probable cause for the chromosomal deletion and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, combined or sequential immunomodulatory therapies may permit clonal expansion of malignant hematopoietic progenitors </plain></SENT>
</text></document>